AxoGen Retained Earnings (Accumulated Deficit) 2010-2025 | AXGN
AxoGen retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| AxoGen Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-291 |
| 2023 | $-281 |
| 2022 | $-260 |
| 2021 | $-231 |
| 2020 | $-204 |
| 2019 | $-180 |
| 2018 | $-151 |
| 2017 | $-128 |
| 2016 | $-118 |
| 2015 | $-103 |
| 2014 | $-90 |
| 2013 | $-72 |
| 2012 | $-58 |
| 2011 | $-48 |
| 2010 | $-38 |
| 2009 | $-2 |
| AxoGen Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-295 |
| 2024-12-31 | $-291 |
| 2024-09-30 | $-292 |
| 2024-06-30 | $-290 |
| 2024-03-31 | $-288 |
| 2023-12-31 | $-281 |
| 2023-09-30 | $-277 |
| 2023-06-30 | $-273 |
| 2023-03-31 | $-267 |
| 2022-12-31 | $-260 |
| 2022-09-30 | $-254 |
| 2022-06-30 | $-250 |
| 2022-03-31 | $-242 |
| 2021-12-31 | $-231 |
| 2021-09-30 | $-225 |
| 2021-06-30 | $-218 |
| 2021-03-31 | $-210 |
| 2020-12-31 | $-204 |
| 2020-09-30 | $-198 |
| 2020-06-30 | $-196 |
| 2020-03-31 | $-188 |
| 2019-12-31 | $-180 |
| 2019-09-30 | $-173 |
| 2019-06-30 | $-167 |
| 2019-03-31 | $-160 |
| 2018-12-31 | $-151 |
| 2018-09-30 | $-145 |
| 2018-06-30 | $-141 |
| 2018-03-31 | $-134 |
| 2017-12-31 | $-128 |
| 2017-09-30 | $-126 |
| 2017-06-30 | $-124 |
| 2017-03-31 | $-122 |
| 2016-12-31 | $-118 |
| 2016-09-30 | $-112 |
| 2016-06-30 | $-110 |
| 2016-03-31 | $-107 |
| 2015-12-31 | $-103 |
| 2015-09-30 | $-100 |
| 2015-06-30 | $-97 |
| 2015-03-31 | $-94 |
| 2014-12-31 | $-90 |
| 2014-09-30 | $-84 |
| 2014-06-30 | $-80 |
| 2014-03-31 | $-77 |
| 2013-12-31 | $-72 |
| 2013-09-30 | $-68 |
| 2013-06-30 | $-65 |
| 2013-03-31 | $-61 |
| 2012-12-31 | $-58 |
| 2012-09-30 | $-54 |
| 2012-06-30 | $-52 |
| 2012-03-31 | $-51 |
| 2011-12-31 | $-48 |
| 2011-09-30 | $-46 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-2 |
| 2010-12-31 | $-38 |
| 2010-09-30 | $-1 |
| 2010-06-30 | $0 |
| 2010-03-31 | $-2 |
| 2009-12-31 | $-2 |
| 2009-09-30 | $-13 |
| 2009-06-30 | $-12 |
| 2009-03-31 | $-13 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.423B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.611B | 79.98 |
| Thermo Fisher Scientific (TMO) | United States | $148.189B | 17.92 |
| Edwards Lifesciences (EW) | United States | $43.397B | 28.45 |
| Alcon (ALC) | Switzerland | $41.812B | 28.26 |
| IDEXX Laboratories (IDXX) | United States | $41.807B | 48.04 |
| DexCom (DXCM) | United States | $31.765B | 49.10 |
| IQVIA Holdings (IQV) | United States | $26.748B | 14.98 |
| Mettler-Toledo (MTD) | United States | $23.806B | 28.31 |
| STERIS (STE) | Ireland | $23.238B | 25.59 |
| Waters (WAT) | United States | $20.195B | 28.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.992B | 0.00 |
| Hologic (HOLX) | United States | $14.255B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.670B | 30.27 |
| Penumbra (PEN) | United States | $9.953B | 78.12 |
| Masimo (MASI) | United States | $8.825B | 32.55 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.848B | 0.00 |
| Teleflex (TFX) | United States | $5.202B | 8.59 |
| TransMedics (TMDX) | United States | $4.194B | 91.18 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.301B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.463B | 14.67 |
| Veracyte (VCYT) | United States | $2.100B | 29.47 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Alphatec Holdings (ATEC) | United States | $1.592B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.359B | 0.00 |
| Artivion (AORT) | United States | $1.268B | 118.80 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.926B | 4.92 |
| Beta Bionics (BBNX) | United States | $0.771B | 0.00 |
| IRadimed (IRMD) | United States | $0.743B | 37.71 |
| SiBone (SIBN) | United States | $0.711B | 0.00 |
| RxSight (RXST) | United States | $0.564B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.507B | 11.89 |
| Delcath Systems (DCTH) | United States | $0.493B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.356B | 9.48 |
| NeuroPace (NPCE) | United States | $0.348B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.343B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.39 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |